Does TOCILIZUMAB Cause Hepatic cirrhosis? 903 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 903 reports of Hepatic cirrhosis have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.9% of all adverse event reports for TOCILIZUMAB.
903
Reports of Hepatic cirrhosis with TOCILIZUMAB
0.9%
of all TOCILIZUMAB reports
470
Deaths
418
Hospitalizations
How Dangerous Is Hepatic cirrhosis From TOCILIZUMAB?
Of the 903 reports, 470 (52.0%) resulted in death, 418 (46.3%) required hospitalization, and 342 (37.9%) were considered life-threatening.
Is Hepatic cirrhosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 903 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Hepatic cirrhosis?
ADALIMUMAB (1,760)
METHOTREXATE (1,650)
ETANERCEPT (931)
RITUXIMAB (863)
INFLIXIMAB (831)
ABATACEPT (824)
HYDROXYCHLOROQUINE (807)
LEFLUNOMIDE (780)
SULFASALAZINE (760)
USTEKINUMAB (753)
Which TOCILIZUMAB Alternatives Have Lower Hepatic cirrhosis Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE